Copyright © 2021 pubrica. All rights reserved 1

The Role of Packaging Design In Drug

Development

Dr. Nancy Agnes, Head, Technical Operations, Pubrica, sales@pubrica.com

Keywords: medication development measure, active

drug ingredients, Source of the API, and excipient,

conventional packaging materials, role of the

packaging technologist,

I. INTRODUCTION

Packaging is a significant segment in developing

different drugs, as it can incredibly influence drug

security and wellbeing. Packaging material is picked

based on its viability and different attributes that

empower it to save the quality, power, and health of

the drug items. As the business advances, the

packaging is getting more significant both to the

fruitful promoting of items and to the health and

security of patients. As an outcome, there are more

reasons than any time in recent memory to

incorporate bundling contemplations from the get-go

in the medication development measure.

II. PACKAGING IS KEY TO MAINTAINING

DRUG STABILITY

Stability testing of drug items and similarity testing

of packaging materials are fundamental pieces of

R&D in the drug business. The security of

medication in solid and fluid measurement structures

relies upon the adequacy of the bundling materials to

shield the medication from compound debasement

and changes in essential qualities like appearance,

hardness, friability, disintegration, deterioration,

weight variety, dampness content, and mechanical

toughness. This is exceptionally fundamental for the

capacity of items under speed-up conditions.

Copyright © 2021 pubrica. All rights reserved 2

III. PACKAGING CONSIDERATIONS FOR

GENERICS

Generic companies frequently follow the innovator or

reference bundling for their item. However, the

nonexclusive medication item plan group needs to

consider the significance of bundling at a previous

phase of improvement. Albeit the name of the

medication item is something similar, there might be

numerous distinctions in the item, for example,

1. Source of the API, and excipient.

2. Quantitative extents of active drug

ingredients.

3. Drug producing process and parameters

because of the presence of licenses and exclusivity.

IV. NEW HEALTHCARE MARKETS BRING

NEW CHALLENGES

Packaging in the healthcare industry faces various

obstacles, including ever-increasing regulatory

requirements in a number of countries. Packaging

changes are being driven by complex

molecules/formulas and biologics, which interfere

with traditional packaging materials. With the

growing demand for new packaging materials and the

need to maintain product-package compatibility

during the R&D stage to ensure the materials'

protection, the task of the packaging technologist

should not be overlooked during the product

development process.

Industry developments are driving the use of cost-

effective, creative packaging solutions today. This is

also another reason why it is important to consider

packaging during the early stages of drug production

to prevent any surprises during commercialization.

To be effective, changes in hospital administration

toward more self-administration processes necessitate

consistent medical communication of product usages,

packaging system simplification, and highly

compliant packaging.

Although packaging is crucial for the marketing of

any pharmaceutical product, pharmaceutical

packaging is heavily regulated. As a result, it is

critical for pharma R&D packaging professionals to

strike a balance between meeting safety, efficiency,

and regulatory requirements while minimising costs

during the early stages of production.

V. CONCLUSION

In recent years, there has been a larger focus on

protecting drug transportation (cold chain, drop

checks, etc.) and maintaining drug purity (track and

trace, serialisation), both of which include packaging

R&D.

REFERENCES

1. Pestana, R. C., Sen, S., Hobbs, B. P., & Hong, D.

S. (2020). Histology-agnostic drug

development—considering issues beyond the

tissue. Nature Reviews Clinical Oncology, 17(9),

555-568.

2. Karapinar‐Çarkit, F., van den Bemt, P. M.,

Sadik, M., van Soest, B., Knol, W., van Hunsel,

F., & van Riet‐Nales, D. A. (2020).

Opportunities for changes in the drug product

design to enhance medication safety in older

people: Evaluation of a national public portal for

medication incidents. British Journal of Clinical

Pharmacology, 86(10), 1946-1957.

3. Kasar, P. M., Tribhuwan, C. S., & Khode, J. G.

(2020). Innovative Packaging of Medicines.

Asian Journal of Research in Pharmaceutical

Science, 10(1).

4. Rehman, A., Jafari, S. M., Aadil, R. M.,

Assadpour, E., Randhawa, M. A., & Mahmood,

S. (2020). Development of active food packaging

via incorporation of biopolymeric nanocarriers

containing essential oils. Trends in Food Science

& Technology.